As a newly approved medication, Foundayo is a first-moverlittle patient-facing coverage information exists yet, which is why this Medicare guide focuses on the one pathway that's live today: the $50 GLP-1 Bridge
Understanding the GLP-1 consumer The GLP-1 era has given rise to multiple distinct consumer types, each with shared, yet nuanced, nutritional needs: Consumers currently using GLP-1 therapies face unique challenges, including appetite suppression that can make meeting nutritional requirements difficult, potential gastrointestinal side effects and concerns about maintaining muscle mass during weight loss
J Am Heart Assoc 7:e007165
What Are CPT Codes
Here's what you need to know about GLP-1 medications and their potential role in addiction treatment
The indications, safety, efficacy, and mechanisms of action of GLP-1R agonists in AIS patients will be the focus of clinical trials